Table 2 Review of false negative NIPS-Plus results
From: Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes
Sample number | MMS | NIPS-Plus Z-score | FF | Prenatal/postnatal findings |
---|---|---|---|---|
FN-1 | T21 | 0.23 | 13.3% | T21: Not detected by ultrasound, diagnosed at birth |
FN-2 | T21 | 0.97 | 9.8% | T21: Not detected by ultrasound, diagnosed at birth |
FN-3 | T21 | 0.54 | 23.1% | T21: Not detected by ultrasound, diagnosed at birth |
FN-4 | T18 | 0.41 | 4.8% | T18: Detected by ultrasound, TOP |
FN-5 | T18 | 1.38 | 15% | T18: Detected by ultrasound, TOP |
FN-6 | DGS | −1.20 | 11% | DGS: Detected by ultrasound, confirmed by SNP array, TOP |
FN-7 | DGS | −1.63 | 9.5% | DGS: Detected by ultrasound, confirmed by SNP array, TOP |
FN-8 | 1p36 del | 1.97 | 12% | 1p36 del: Not detected by ultrasound, diagnosed at birth |
FN-9 | PWS | −2.78 | 17% | PWS: Not detected by ultrasound, diagnosed at birth |
FN-10a | CDC | −2.04 | 16% | PWS: Detected by ultrasound, confirmed by SNP array, TOP |